Research, data analysis, and commentary on abortion and declining birth rates.
On 28 April 2025, the Ethics and Public Policy Center (EPPC) published the largest-known study into complications arising from the use of the abortion pills.[i] Jamie Bryan Hall and Ryan T. Anderson, analysed data from a U.S. insurance claims database that included 865,727 patient cases in which mifepristone had been prescribed for an induced medical... Continue Reading →
Yes. The RCOG states that in up to 1% of all cases pregnancy continues after the woman has taken the abortion pills and that in up 6% of all cases the abortion is incomplete; another procedure is required to correct both types of treatment failure. That said, some only consider ‘failure’ to include the first... Continue Reading →
Medical Abortion (MA), aka the abortion pill, doesn’t always work; it is well-established that MA has an expected and commonly occurring treatment failure rate of about 5%. Meaning that as many as 1-in-20 pregnant women using abortion pills will subsequently need additional medical treatment for complications arising from an incomplete abortion. Medical abortion treatment failure... Continue Reading →
New York Times review Research shows that the abortion pill fails in 5% of cases – that’s the findings from a New York Times review of 101 studies covering 124,000 first trimester abortions performed in 26 countries over the last 30 years. Non-negligible risk of failure. It is well-known that medical abortion will sometimes fail,... Continue Reading →
Medical abortion doesn't always work; it is well established that MA has an expected treatment failure rate of about 6%. Which means that as many as 1-in-17 pregnant women using abortion pills will subsequently need hospital treatment for complications arising from an incomplete abortion. Ranbaxy (UK) Limited is the manufacturer of Medabon, the mifepristone/misoprostol combination... Continue Reading →
In its SmPC (summaries of product characteristics), Ranbaxy states that there is a non-negligible risk of medical abortion treatment failure, as follows: The non-negligible risk of failure, which occurs in 4.5 to 7.8% of the cases, makes the follow-up visit mandatory in order to check that abortion is complete. The patient should be informed that... Continue Reading →
